NASDAQ$NTRA

Natera Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Natera reported a 53.9% increase in total revenues driven by product revenues growth.

Natera's Q4 2021 total revenues increased by 53.9% compared to Q4 2020, driven by product revenue growth. The company processed 438,800 tests in the fourth quarter of 2021, including 424,200 tests accessioned in its laboratory.

  • Total revenues were $173.0 million, a 53.9% increase compared to Q4 2020.
  • Product revenues were $160.9 million, a 51.1% increase compared to Q4 2020.
  • Approximately 438,800 tests were processed in Q4 2021.
  • Net loss for the fourth quarter of 2021 was $140.6 million, or ($1.48) per diluted share.

Headline financials

Total Revenue

$173M

Previous: $112M+53.9%
EPS (adj)

-$1.48

Previous: -$0.89-66.3%
Tests processed

438.8K

Previous: 295.0K+48.7%
Tests accessioned

424.2K

Previous: 281.0K+51.0%
Tests reported

410.9K

Previous: 281.4K+46.0%
Tests reported (lab)

397.1K

Previous: 268.3K+48.0%
Capital Expenditures

$9M

Previous: $7.53M+19.5%
Free Cash Flow

-$108M

Previous: -$80.8M-33.3%
Net Income

-$141M

Previous: -$76.4M-84.0%
Operating Income

-$140M

Previous: -$74M-88.8%
Gross Profit

$78.9M

Previous: $52.5M+50.3%
Cash & Equivalents

$915M

Previous: $738M+24.0%
Total Assets

$1.24B

Previous: $932M+32.6%
Stock-Based Comp

$30.4M

Previous: $15.8M+93.0%

Revenue & EPS history

Natera · Revenue · Quarterly

$173M

Q4 2021+53.9%vs Q4 2020
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Revenue by segment

Natera · $33.9M total across 1 segment · Q1 2021

  • Licensing and other revenues
    $33.9M

Forward guidance

Natera anticipates 2022 total revenue of $770 million to $790 million; 2022 gross margin to be approximately 46% to 48% of revenues; selling, general and administrative costs to be approximately $560 million to $590 million; research and development costs to be $340 million to $360 million, and net cash consumption to be $370 million to $400 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+4.4%

Avg return

Earnings day

+4.4%

Avg return

5 days after

+6.0%

Avg return

30 days after

69%

31 / 45 earnings

Positive

+29.1%

Q2 2017

Best reaction

-21.2%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-5.2%+0.0%
Q4 2025-3.8%-6.0%-15.5%
Q3 2025+0.7%+5.6%+23.2%
Q1 2025-6.9%-6.9%+0.7%
Q4 2024-0.7%-5.5%-8.1%
Q3 2024+20.2%+9.0%+24.2%
Q2 2024+14.2%+18.6%+12.5%
Q1 2024+10.1%+10.3%+16.2%
Q4 2023+13.6%+18.4%+20.1%
Q3 2023+4.0%+11.2%+33.2%
Q2 2023+16.1%+20.0%+42.3%
Q1 2023-3.6%-3.8%-8.1%
Q4 2022+14.1%+22.2%+14.1%
Q3 2022-13.2%-5.3%-9.2%
Q2 2022+5.1%+3.7%-2.7%
Q1 2022-2.0%-18.5%+0.5%
Q4 2021+10.2%+5.9%-34.7%
Q3 2021+3.6%+1.2%-22.7%
Q2 2021+2.4%-7.7%+8.1%
Q1 2021-2.9%-14.0%-7.1%
Q4 2020+2.9%+4.6%-17.0%
Q3 2020+9.3%+2.3%+16.5%
Q2 2020+11.8%+4.0%+31.2%
Q1 2020+19.8%+28.3%+11.6%
Q4 2019+6.4%+5.6%-27.3%
Q3 2019-3.7%+0.3%-1.3%
Q2 2019+19.3%+9.6%+19.8%
Q1 2019+19.8%+26.8%+34.3%
Q4 2018+19.6%+16.9%+22.9%
Q3 2018-21.2%-25.2%-20.4%
Q2 2018+0.2%+5.2%+8.4%
Q1 2018+1.4%-0.9%+3.6%
Q4 2017+0.3%+17.3%+10.1%
Q3 2017-12.8%-13.4%-11.9%
Q2 2017+29.1%+32.4%+64.0%
Q1 2017+13.8%+11.5%+7.1%
Q4 2016-14.8%-15.9%-10.8%
Q3 2016+12.0%+25.5%+26.8%
Q2 2016-5.8%-17.2%-21.3%
Q1 2016+15.4%
Q1 2014+0.1%
Q4 2015-13.8%
Q3 2014+2.7%
Q3 2015+7.0%
Q2 2014-3.6%
Q1 2015
Q4 2014
Q4 2013
Q3 2013
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro